Healthcare AI Deployment Readiness System: Governance Framework, Risk Register, Structured Evaluation, Executive Documentation

When your organization deploys AI in patient care, critical governance questions often lack a documented, consistent answer: Is the system regulated as FDA Software as a Medical Device (SaMD)? Do all vendors with access to protected health information (PHI) have signed Business Associate Agreements? Has the system undergone clinical validation? What are the human override procedures in safety-critical scenarios?

In many organizations, these determinations exist only in scattered emails, spreadsheets, and individual institutional knowledge. As a result, there is no unified governance record showing how deployment decisions were evaluated, justified, and approved.

The Healthcare AI Deployment Readiness System provides a structured evaluation framework for clinical AI governance decisions. It organizes deployment assessment across six domains: patient safety, HIPAA and PHI governance, clinical decision support, FDA/SaMD classification, provider governance, and patient consent. It produces a complete, timestamped audit trail of evaluation decisions, a unified risk register, and a board-ready executive summary documenting the rationale behind the deployment recommendation.

What’s Inside

Hard-Stop Governance Logic
Critical regulatory and safety conditions—such as missing Business Associate Agreements, absence of clinician override mechanisms, or unresolved FDA/SaMD classification status—trigger required-resolution flags. Deployment cannot be marked “Ready” while unresolved hard-stop conditions remain open.

Six Weighted Evaluation Domains
Structured assessment across Patient Safety, HIPAA & PHI, Clinical Decision Support, FDA/SaMD Classification, Provider Governance, and Patient Consent. FDA/SaMD evaluation is dynamically weighted based on applicability, with redistribution across remaining domains when not applicable.

Structured Governance Record (Audit Trail)
Generates a timestamped record of every evaluation decision, including assessed criteria, supporting rationale, and reviewer inputs. Designed to support internal AI governance committees and external audit review.

Executive Summary (Board-Ready Output)
A concise, single-page summary designed for clinical leadership and governance committees. Presents evaluation status, unresolved risks, and final recommendation in a format readable within minutes.

Unified Risk Register
Consolidates all identified gaps across domains into a centralized register, automatically prioritized by severity. Ensures no evaluation gaps are lost across distributed systems or documentation silos.

Built-In Regulatory Framework Layer
Incorporates HIPAA safeguards, FDA SaMD classification pathways, Predetermined Change Control Plan concepts for adaptive AI systems, clinical validation principles, and the 18 HIPAA identifiers as structural inputs for evaluation.

How It Works

Initialize System Context
Define the AI system, clinical environment, and deployment scope. Establish baseline governance context for evaluation.

Complete Six Evaluation Modules
Work through structured assessments covering:

• Patient Safety (validation, human override, confidence thresholds)

• HIPAA & PHI (data handling, safeguards, BAA tracking)

• Clinical Decision Support (workflow integration, alert design)

• FDA/SaMD Classification (regulatory status and pathway assessment)

• Provider Governance (institutional policies and oversight structure)

• Patient Consent (consent model and documentation requirements)

Generate Governance Outputs
The system produces an Executive Summary, Unified Risk Register, and Timestamped Audit Trail. Outputs are exported as governance artifacts for AI evaluation committees, compliance teams, and clinical leadership.

Final recommendation is classified as: Ready, Not Ready, or Ready with Conditions, with full traceability to underlying evaluation inputs and rationale.

Who It’s For

CMOs, Chief Medical Informatics Officers, Compliance Officers, AI Governance Committee members, and clinical leadership responsible for approving or overseeing AI deployment in healthcare environments.

Outcome

Move from fragmented, informal AI deployment decision-making to a structured evaluation process that documents regulatory review, clinical safety considerations, and governance decisions in an auditable format.

FAQ

Does this guarantee compliance with FDA, HIPAA, or other regulations?
No. Regulatory compliance depends on your organization’s implementation, environment, and applicable regulatory interpretation. This system structures the evaluation process and documents governance decisions; it does not certify compliance or approve deployments.

Does this require internet access or a cloud account?
No. The system runs entirely offline as a self-contained HTML file in a browser. No login, external connectivity, or cloud storage is required. All data remains local to the user’s device.

What does the license cover?
Single-organization use. Generated outputs—including executive summaries, risk registers, and audit trails—may be used internally for governance and compliance purposes. The system itself may not be redistributed, resold, or sublicensed. Enterprise or multi-organization licensing is available upon request.

How is this different from a checklist or policy template?
Templates define what should be documented. This system defines what must be evaluated, enforces hard-stop regulatory conditions, weights risk across clinically relevant domains, and produces a structured governance record showing how each deployment decision was reached.